2021. Development and validation of a SEER-based prognostic nomogram for cervical cancer patients below the age of 45 years. Biomolecules and Biomedicine. 21, 5 (Oct. 2021), 620–631. DOI:https://doi.org/10.17305/bjbms.2020.5271.